Sanofi (NASDAQ:SNY) Shares Sold by Motco

Motco lowered its stake in shares of Sanofi (NASDAQ:SNY) by 1.2% during the fourth quarter, Holdings Channel reports. The firm owned 80,569 shares of the company’s stock after selling 993 shares during the period. Motco’s holdings in Sanofi were worth $3,886,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of SNY. Synergy Asset Management LLC acquired a new stake in Sanofi during the 4th quarter worth $25,000. McClarren Financial Advisors Inc. lifted its holdings in shares of Sanofi by 952.6% in the 4th quarter. McClarren Financial Advisors Inc. now owns 600 shares of the company’s stock valued at $28,000 after purchasing an additional 543 shares during the last quarter. Sunbelt Securities Inc. boosted its position in shares of Sanofi by 72.1% in the 3rd quarter. Sunbelt Securities Inc. now owns 747 shares of the company’s stock valued at $43,000 after purchasing an additional 313 shares during the period. Sierra Ocean LLC purchased a new position in Sanofi during the 4th quarter worth approximately $44,000. Finally, Versant Capital Management Inc acquired a new position in Sanofi during the fourth quarter worth approximately $54,000. Hedge funds and other institutional investors own 14.04% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on SNY. StockNews.com downgraded Sanofi from a “buy” rating to a “hold” rating in a report on Thursday, December 12th. Sanford C. Bernstein raised shares of Sanofi to a “strong-buy” rating in a research report on Thursday, January 30th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Sanofi from a “sell” rating to a “hold” rating in a report on Thursday, January 30th. Two research analysts have rated the stock with a hold rating, one has assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of $60.00.

Sanofi Trading Down 1.5 %

NASDAQ:SNY opened at $54.14 on Friday. Sanofi has a 12-month low of $45.22 and a 12-month high of $58.97. The company has a current ratio of 1.46, a quick ratio of 1.14 and a debt-to-equity ratio of 0.15. The stock’s 50 day simple moving average is $51.51 and its 200-day simple moving average is $52.59. The firm has a market cap of $137.40 billion, a P/E ratio of 21.74, a PEG ratio of 1.01 and a beta of 0.57.

Sanofi (NASDAQ:SNY) last announced its quarterly earnings data on Thursday, January 30th. The company reported $0.70 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.70. Sanofi had a net margin of 12.77% and a return on equity of 25.61%. Equities analysts anticipate that Sanofi will post 4.36 EPS for the current year.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.